Browsing the "Fidelity Biosciences" Tag →

20 2015 May
By FinSMEs
0 Comments

Regenxbio Closes $70.5M in Series D Funding

Regenxbio, a Rockville, Maryland-based gene therapy-focused biotech company, closed $70.5m in Series D funding. The round, which brought total funding...

Read More →
15 2015 May
By FinSMEs
0 Comments

Denali Therapeutics Launches with $217M in Funding

Denali Therapeutics Inc., a San Francisco, CA-based biotechnology company that develops treatments for neurodegenerative diseases, launched with $217m in funding....

Read More →
11 2015 May
By FinSMEs
0 Comments

Precision BioSciences Closes $25.6M Series A Financing

Precision BioSciences, a Research Triangle Park, N.C.-based genome editing company, closed a $25.6m Series A financing. The round was led...

Read More →
06 2015 May
By FinSMEs
0 Comments

Symbiomix Therapeutics Closes $41M Series A Financing

Symbiomix Therapeutics, a Newark, N.J.-based late-stage, privately held biopharmaceutical company, closed the third and final tranche of a $41m Series...

Read More →
21 2015 April
By FinSMEs
0 Comments

Dimension Therapeutics Completes $65M Series B Financing

Dimension Therapeutics, Inc., a Cambridge, MA-based rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, completed a $65m...

Read More →
02 2015 April
By FinSMEs
0 Comments

Quartet Health Raises $7M in Funding

Quartet Health Inc., a New York-based behavioral health technology company, raised $7m in funding. The round was led by Annie...

Read More →
02 2015 April
By FinSMEs
0 Comments

Caribou Biosciences Closes $11M Series A Financing Round

Caribou Biosciences, a Berkeley, Calif.-based developer of technology-based solutions for cellular engineering and analysis, closed an $11m Series A financing...

Read More →
24 2015 March
By FinSMEs
0 Comments

Semma Therapeutics Closes $44M Series A Funding

Semma Therapeutics, a Cambridge, MA-based developer of a cell therapy for Type 1 diabetes, closed a $44m Series A funding....

Read More →
02 2015 March
By FinSMEs
0 Comments

Mersana Therapeutics Raises $35M in Series B-1 Financing

Mersana Therapeutics, Inc., a Cambridgre, MA-based drug developer, raised $35m in Series B-1 financing. The round was led by existing...

Read More →
18 2015 February
By FinSMEs
0 Comments

TraceLink Raises $20M in Venture Funding

TraceLink Inc., a Wakefield, MA-based provider of solutions for Life Sciences companies to protect patients From counterfeit drugs, raised $20m...

Read More →
26 2015 January
By FinSMEs
0 Comments

Iora Health Raises $28M in Series C Funding

Iora Health, a Cambridge, Massachusetts-based healthcare company, raised $28m in Series C funding. Backers included Foundation Medical Partners, Rice Management...

Read More →
22 2015 January
By FinSMEs
0 Comments

Innovent Biologics Raises $100M in Series C Financing

Innovent Biologics, Inc., a Shangai, China-based biopharmaceutical company, raised $100m in Series C financing. The round was led by Legend...

Read More →
21 2015 January
By FinSMEs
0 Comments

Regenxbio Closes $30M in Series C Funding

Regenxbio, a Washington, DC-based gene therapy biotech company, closed $30m in Series C funding. The round was led by Venrock...

Read More →
08 2015 January
By FinSMEs
0 Comments

Surface Oncology Closes $35M Series A Funding Round

Surface Oncology, a Cambridge, Mass.-based company developing cancer immunotherapies, closed a $35m Series A funding round. Backers included The Atlas...

Read More →